Nurse Navigation Versus Current Care Coordination During Colorectal Cancer Trajectories
NaviCan
NaviCan. Navigation and Support to Cancer Patients - A Randomized Controlled Trial.
2 other identifiers
interventional
280
0 countries
N/A
Brief Summary
In western countries, the number of cancer survivors increases, and current cancer care seems insufficient with both patients' experiences of lack of help in transitions and up to 60 % of the patients having psychological problems after treatment. Further, Denmark shall have new hospitals, where researchers and healthcare professionals are expected to merge tasks and reach a higher patient experienced quality of care, without additional costs, so a better way to provide cancer care, which benefits the patients and supports the ideas within the new hospitals in Denmark, is needed. In a randomized controlled trial, the organizational structure of the healthcare system is challenged and the impact of a coherent nurse navigation practice compared to the currently existing department-specific care coordination is tested. The primary data are changes in patients' self-reported cancer-related self-efficacy from inclusion till one week after receipt of the information that they have reached the end of treatment, or in case of prolonged treatment, till not later than one year after inclusion. Patients can participate if they are 18 years of age or older, speak and understand Danish, and have a proven lesion suspected of cancer in the colon or rectum after colonoscopy or sigmoidoscopy at the Danish endoscopy centers at Odense University Hospital (the cities: Nyborg, Svendborg and Odense) or at Slagelse Hospital. Furthermore, participants must not be mentally retarded, they must not suffer from a constant life-threatening disease, and they must not suffer from, or be in the diagnostic phase of, dementia or severe psychiatric disease. Participants are allocated to support from nurse navigation or to current care coordination, and fill in four questionnaires during their cancer trajectory: 1) At inclusion, 2) Three days before treatment start, 3) One week after receipt of information about treatment end or not later than one year after inclusion, and 4) Six weeks after measure point 3. Data is analyzed using suitable statistical models. With positive results, participants in nurse navigation are better helped during their cancer trajectory and have a better psychological start on the rest of their lives after cancer treatment. Focus will be on colon and rectum cancer care, but the results will be transferable to similar settings. Furthermore, positive results will support changes in the onset of rehabilitation initiatives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 26, 2016
CompletedFirst Submitted
Initial submission to the registry
September 11, 2017
CompletedFirst Posted
Study publicly available on registry
September 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedApril 4, 2019
April 1, 2019
1.7 years
September 11, 2017
April 2, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self evaluated Self Efficacy for Cancer
Cancer Behaviour Inventory - Brief
Change in "Cancer Behaviour Inventory - Brief" from inclusion to measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion.
Secondary Outcomes (15)
Self evaluated Self Efficacy for Cancer
Change in "Cancer Behaviour Inventory - Brief" from inclusion to three days before treatment start.
Self evaluated Self Efficacy for Cancer
Change in "Cancer Behaviour Inventory - Brief" from inclusion to six weeks after measurement 3.
Self evaluated Self Efficacy for Cancer
Change in "Cancer Behaviour Inventory - Brief" from three days before treatment start to measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion.
Self evaluated Self Efficacy for Cancer
Change in "Cancer Behaviour Inventory - Brief" from three days before treatment start to six weeks after measurement 3.
Self evaluated Self Efficacy for Cancer
Change in "Cancer Behaviour Inventory - Brief" from one week after measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion to six weeks after measure point 3.
- +10 more secondary outcomes
Study Arms (2)
Nurse navigation
EXPERIMENTALCoherent navigation and support from a family-centred viewpoint throughout the cancer trajectory, despite the individual patient's affiliation to any department.
Current care coordination
ACTIVE COMPARATORDepartment-specific coordination and answers to questions from a patient-centred viewpoint.
Interventions
Eligibility Criteria
You may qualify if:
- Lesions suspected for cancer in the colon or rectum recognized through colonoscopy or sigmoidoscopy found at scopy centres in Odense, Nyborg, Svendborg or Slagelse, all in Denmark
- Can speak and understand Danish.
You may not qualify if:
- Life-threatening disease: score 4 in the American Society of Anaesthesiologists status classification system.
- Dementia ( Diagnosed or in a diagnostic phase).
- Severe psychiatric disease ( Diagnosed or in a diagnostic phase).
- Mentally retarded ( Diagnosed or in a diagnostic phase).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Odense University Hospitallead
- University of Southern Denmarkcollaborator
- Laval Universitycollaborator
- Slagelse Hospitalcollaborator
- Region of Southern Denmarkcollaborator
- Region Zealandcollaborator
- Danish Cancer Societycollaborator
- Odense Patient Data Explorative Networkcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Lise Fillion, PhD
Nursing Faculty, Laval University
- STUDY CHAIR
Jens Søndergaard, PhD
Research Unit of General Practice, Faculty of Health Sciences, University of Southern Denmark
- PRINCIPAL INVESTIGATOR
Marianne K Thygesen, PhD
Surgery department A, Clinical Institute, Faculty of Health Sciences, University of Southern Denmark and OPEN at Region of Southern Denmark
- STUDY DIRECTOR
Niels Qvist, DMSc
Surgery department A, Clinical Institute, Faculty of Health Sciences, University of Southern Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
September 11, 2017
First Posted
September 13, 2017
Study Start
February 26, 2016
Primary Completion
October 23, 2017
Study Completion
December 31, 2018
Last Updated
April 4, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share